Biomarker Tests in North America: Innovations Transforming Diagnostics and Patient Care
Rigorous regulatory frameworks shape the landscape for companion diagnostics and novel biomarker validations, ensuring high standards of safety while encouraging innovation. The country's dense concentration of advanced clinical laboratories and specialized oncology centers enables rapid integration of cutting-edge genomic and proteomic tests into standard patient care. As reimbursement models...
